Maximus IncChange company Symbol lookupSelect an option...MMS Maximus IncNA Nano Labs LtdTCRX TScan Therapeutics IncMET MetLife IncMLEC Moolec Science SAMSFT Microsoft CorpSDA SunCar Technology Group IncSLNH Soluna Holdings IncTPST Tempest Therapeutics IncPETV PetVivo Holdings IncGo
Change company Symbol lookup
Select an option...
MMS Maximus Inc
NA Nano Labs Ltd
TCRX TScan Therapeutics Inc
MET MetLife Inc
MLEC Moolec Science SA
MSFT Microsoft Corp
SDA SunCar Technology Group Inc
SLNH Soluna Holdings Inc
TPST Tempest Therapeutics Inc
PETV PetVivo Holdings Inc
Industrials : Professional Services | Small Cap Blend
Company profileMaximus, Inc. is an operator of government health and human services programs and provider of technology solutions to governments. The Company operates through three segments: U.S. Services, U.S. Federal Services, and Outside the U.S. The U.S. Services segment provides a variety of business process services (BPS), such as program administration, appeals and assessments, and related consulting work for United States state and local government programs. The U.S. Federal Services segment delivers end-to-end solutions that help various United States federal government agencies, including program operations and management, clinical services, and technology solutions. The Outside the U.S. segment provides BPS for international governments and commercial clients. The services provided by the segment include health and disability assessments, program administration for employment services, wellbeing solutions, and other job seeker-related services.
|
|
|
|
| |
| Latest Earnings Missed Consensus (Q2 ending 03/2023) | Next Earnings Announcement | ||||||
|---|---|---|---|---|---|---|---|
| Q2 Non-GAAP earnings GAAP vs. Non-GAAP EarningsTD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts. Announced May 3, 2023 | $0.52 | Q2 Consensus of 2 analysts | $0.69 | Difference from consensus | -24.09% | Q3 Earnings will announce | (Unconfirmed) August 1, 2023 |
Quarterly Earnings History and Estimates
Show high-low estimates
Draw trendlines
Draw up to 3 lines inside the chart.
MMS's fiscal year ends in September
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.
Information provided by Copyright © 2023. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.